Skip to main content

Want a detailed portfolio tracker?

Apogee Therapeutics (APGE) P/E (2023 - 2026)

Apogee Therapeutics (APGE) P/E from Oct 2, 2023 to Jul 21, 2026. The TTM Apogee Therapeutics (APGE) P/E is -31.73. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Apogee Therapeutics (APGE)

YearP/EChange
2026-31.73+76.09%
2025-18.02+26.71%
2024-14.22-77.91%
2023-64.38N/A

Comparison Apogee Therapeutics (APGE) P/E with competitors

Apogee Therapeutics (APGE) P/E is -31.73.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.24%
FGENFibroGen Inc0.24-100.76%
CHRSCoherus Biosciences Inc0.85-102.67%
FBIOFortress Biotech Inc0.95-102.99%
ORMPOramed Pharmaceuticals Inc1.50-104.74%
AGENAgenus Inc3.01-109.48%
INVAInnoviva Inc3.15-109.94%
VXRTVaxart Inc3.55-111.19%
CRMDCorMedix Inc3.63-111.43%
CVACCureVac N.V.4.45-114.01%
GLPGGalapagos NV4.86-115.31%
SRPTSarepta Therapeutics Inc4.88-115.38%
ABEOAbeona Therapeutics Inc5.39-116.98%
ABUSArbutus Biopharma Corp5.60-117.63%
ZVRAZevra Therapeutics Inc5.89-118.55%
SPROSpero Therapeutics Inc6.23-119.63%
CGENCompugen Ltd6.31-119.90%
RIGLRigel Pharmaceuticals6.87-121.66%
SLXNSilexion Therapeutics Corp7.30-122.99%
OMEROmeros Corporation9.26-129.18%
AUPHAurinia Pharmaceuticals Inc9.58-130.20%
PLXProtalix BioTherapeutics Inc10.89-134.32%
ACADAcadia Pharmaceuticals Inc11.73-136.96%
TBPHTheravance Biopharma Inc12.26-138.64%
ADMAAdma Biologics Inc12.42-139.13%
HRMYHarmony Biosciences Holdings Inc13.82-143.55%
SABSSAB Biotherapeutics Inc14.14-144.55%
NAGENiagen Bioscience Inc14.82-146.69%
INCYIncyte Corp15.82-149.86%
REGNRegeneron Pharmaceuticals Inc15.86-149.97%
PBYIPuma Biotechnology Inc17.32-154.57%
CPRXCatalyst Pharmaceuticals Inc17.44-154.95%
EXELExelixis Inc17.54-155.27%
TGTXTG Therapeutics Inc18.97-159.77%
MDXGMimedx Group Inc20.55-164.77%
XOMAXOMA Royalty Corp22.87-172.08%
ARGXArgen X SE24.30-176.57%
CTMXCytomX Therapeutics Inc24.82-178.22%
XOMAOXOMA Royalty Corp25.34-179.87%
HALOHalozyme Therapeutics Inc25.62-180.75%
XOMAPXOMA Royalty Corp25.67-180.89%
VRTXVertex Pharmaceuticals Inc27.99-188.22%
RPRXRoyalty Pharma plc - Class A28.69-190.40%
SLNOSoleno Therapeutics Inc29.02-191.44%
ASNDAscendis Pharma A/S30.09-194.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91-219.47%
BMRNBiomarin Pharmaceutical Inc42.21-233.02%
KRYSKrystal Biotech Inc45.34-242.89%
ONCBeiGene Ltd69.54-319.14%
PHARPharming Group N.V.75.03-336.43%
TECHBio-Techne Corp101.96-421.30%
VCELVericel Corp109.92-446.39%
ALNYAlnylam Pharmaceuticals Inc117.96-471.74%
GMABGenmab140.29-542.10%
TLXTelix Pharmaceuticals Ltd162.15-610.99%
CORTCorcept Therapeutics Inc212.86-770.77%